Trials / Conditions / Recurrent Retinoblastoma
Recurrent Retinoblastoma
3 registered clinical trials studyying Recurrent Retinoblastoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors NCT00831844 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Yo NCT00690469 | Children's Oncology Group | — |
| Completed | Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas NCT00012181 | National Cancer Institute (NCI) | Phase 1 |